pyrrolidonecarboxylic acid has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, JF; Rieke, GK; Scarfe, AD | 1 |
| Howard, R; Idusuyi, OB; Rieke, GK; Semenya, J; Smith, J; Williams, S | 1 |
| Lange, H; Uhlhaas, S | 1 |
3 other study(ies) available for pyrrolidonecarboxylic acid and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
L-pyroglutamate: an alternate neurotoxin for a rodent model of Huntington's disease.
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Disease Models, Animal; Huntington Disease; Kainic Acid; Male; Mice; Microscopy, Electron; Pyrrolidinones; Pyrrolidonecarboxylic Acid | 1984 |
Chronic intrastriatal L-pyroglutamate: neuropathology and neuron sparing like Huntington's disease.
Topics: Animals; Corpus Striatum; Huntington Disease; Male; NADPH Dehydrogenase; Neurons; Neurotoxins; Pyrrolidinones; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Somatostatin | 1989 |
Striatal deficiency of L-pyroglutamic acid in Huntington's disease is accompanied by increased plasma levels.
Topics: Adult; Age Factors; Aged; Corpus Striatum; Humans; Huntington Disease; Middle Aged; Pyrrolidinones; Pyrrolidonecarboxylic Acid; Substantia Nigra | 1988 |